Patrick Haslett

5.5k total citations · 2 hit papers
57 papers, 4.3k citations indexed

About

Patrick Haslett is a scholar working on Immunology, Virology and Infectious Diseases. According to data from OpenAlex, Patrick Haslett has authored 57 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 16 papers in Virology and 12 papers in Infectious Diseases. Recurrent topics in Patrick Haslett's work include HIV Research and Treatment (16 papers), Multiple Myeloma Research and Treatments (12 papers) and Immune Cell Function and Interaction (11 papers). Patrick Haslett is often cited by papers focused on HIV Research and Treatment (16 papers), Multiple Myeloma Research and Treatments (12 papers) and Immune Cell Function and Interaction (11 papers). Patrick Haslett collaborates with scholars based in United States, United Kingdom and South Africa. Patrick Haslett's co-authors include Gilla Kaplan, Laura G. Corral, George W. Muller, David Stirling, Christopher Ocampo, Matthew L. Albert, Willem A. Hanekom, Lai Mun Wong, Roger Chen and Victoria H. Freedman and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and Gastroenterology.

In The Last Decade

Patrick Haslett

57 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha.

1999 635 citations Laura G. Corral, Patrick Haslett et al. PubMed profile →
Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α

1999 577 citations Laura G. Corral, Patrick Haslett et al. The Journal of Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Haslett United States	32	1.5k	1.5k	1.2k	841	831	57	4.3k
Vito Racanelli Italy	47	1.7k 1.1×	813 0.6×	2.0k 1.6×	413 0.5×	1.6k 1.9×	151	6.5k
Giovanni Migliaccio Italy	46	2.5k 1.7×	2.4k 1.6×	1.1k 0.9×	1.0k 1.2×	538 0.6×	190	7.2k
Giovanni Barillari Italy	35	1.5k 1.0×	455 0.3×	1.1k 0.9×	756 0.9×	2.0k 2.4×	141	6.0k
Kazunaga Agematsu Japan	42	1.3k 0.9×	472 0.3×	3.2k 2.6×	463 0.6×	427 0.5×	135	5.1k
Jean Plum Belgium	41	1.7k 1.1×	556 0.4×	2.5k 2.0×	807 1.0×	903 1.1×	168	5.3k
Åke Öst Sweden	35	720 0.5×	2.0k 1.4×	977 0.8×	694 0.8×	868 1.0×	112	4.4k
Robertson Parkman United States	44	1.3k 0.9×	2.7k 1.8×	3.1k 2.5×	357 0.4×	1.0k 1.2×	169	6.8k
Pierre‐Simon Rohrlich France	33	671 0.5×	906 0.6×	1.1k 0.9×	462 0.5×	670 0.8×	138	3.5k
Fabrice Cognasse France	37	681 0.5×	1.8k 1.2×	1.3k 1.0×	256 0.3×	368 0.4×	142	5.0k
JE Groopman United States	34	604 0.4×	1.4k 0.9×	1.5k 1.2×	967 1.1×	793 1.0×	55	4.5k

Countries citing papers authored by Patrick Haslett

Since Specialization

Citations

This map shows the geographic impact of Patrick Haslett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Haslett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Haslett more than expected).

Fields of papers citing papers by Patrick Haslett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Haslett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Haslett. The network helps show where Patrick Haslett may publish in the future.

Co-authorship network of co-authors of Patrick Haslett

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Haslett. A scholar is included among the top collaborators of Patrick Haslett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Haslett. Patrick Haslett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mâncio-Silva, Liliana, Heather E. Fleming, A. B. Miller, et al.. (2019). Improving Drug Discovery by Nucleic Acid Delivery in Engineered Human Microlivers. Cell Metabolism. 29(3). 727–735.e3. 10 indexed citations

Whitley, Chester B., Maureen Cleary, Eugen Mengel, et al.. (2018). Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B. The Journal of Pediatrics. 197. 198–206.e2. 25 indexed citations

Jones, Simon, Catherine Breen, Stewart Rust, et al.. (2016). A phase 1/2 study of intrathecal heparan-N-sulfatase in patients with mucopolysaccharidosis IIIA. Molecular Genetics and Metabolism. 118(3). 198–205. 83 indexed citations

Powell, Kendall D., Jiang Wu, Thomas McCauley, et al.. (2016). A Novel LC–MS/MS Assay for Heparan Sulfate Screening in The Cerebrospinal Fluid of Mucopolysaccharidosis Iiia Patients. Bioanalysis. 8(4). 285–295. 19 indexed citations

Liebow, Abigail, Xingsheng Li, Timothy Racie, et al.. (2016). An Investigational RNAi Therapeutic Targeting Glycolate Oxidase Reduces Oxalate Production in Models of Primary Hyperoxaluria. Journal of the American Society of Nephrology. 28(2). 494–503. 159 indexed citations

Sehgal, Alfica, Keith Blomenkamp, Amy Simon, et al.. (2015). 279 Pre-Clinical Evaluation of ALN-AAT to Ameliorate Liver Disease Associated With Alpha-1-Antitrypsin Deficiency. Gastroenterology. 148(4). S–975. 8 indexed citations

Krueger, James G., Scott Fretzin, Mayte Suárez‐Fariñas, et al.. (2012). IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis. Journal of Allergy and Clinical Immunology. 130(1). 145–154.e9. 300 indexed citations

Martiniuk, Frank, et al.. (2012). Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.. PubMed. 11(5). 626–30. 34 indexed citations

Abbo, Lilian M., Vladimir Vincek, Gordon M. Dickinson, et al.. (2007). Selective Defect in Plasmacyoid Dendritic Cell Function in a Patient with AIDS-Associated Atypical Genital Herpes Simplex Vegetans Treated with Imiquimod. Clinical Infectious Diseases. 44(3). e25–e27. 31 indexed citations

10.

Siddiqui, Ruby, André L. Moreira, Yohannes Negesse, et al.. (2002). Local Nerve Damage in Leprosy Does Not Lead to an Impaired Cellular Immune Response or Decreased Wound Healing in the Skin. The Journal of Infectious Diseases. 186(2). 260–265. 8 indexed citations

11.

Kaplan, Gilla, Steve D. Thomas, Daniel S. Fierer, et al.. (2000). Thalidomide for the Treatment of AIDS-Associated Wasting. AIDS Research and Human Retroviruses. 16(14). 1345–1355. 67 indexed citations

12.

Shacklett, Barbara L., Paulo Pacheco, James H. Grendell, et al.. (2000). Isolation of Cytomegalovirus-Specific Cytotoxic T-Lymphocytes from Gut-Associated Lymphoid Tissue (GALT) of HIV Type 1-Infected Subjects. AIDS Research and Human Retroviruses. 16(12). 1157–1162. 7 indexed citations

13.

Shacklett, Barbara L., Paulo Pacheco, James H. Grendell, et al.. (2000). Characterization of HIV-1-Specific Cytotoxic T Lymphocytes Expressing the Mucosal Lymphocyte Integrin CD103 in Rectal and Duodenal Lymphoid Tissue of HIV-1-Infected Subjects. Virology. 270(2). 317–327. 28 indexed citations

14.

Granelli‐Piperno, Angela, et al.. (2000). Dendritic Cells, Infected with Vesicular Stomatitis Virus-Pseudotyped HIV-1, Present Viral Antigens to CD4+ and CD8+ T Cells from HIV-1-Infected Individuals. The Journal of Immunology. 165(11). 6620–6626. 38 indexed citations

15.

Bekker, Linda‐Gail, Patrick Haslett, Gary Maartens, Lafras M. Steyn, & Gilla Kaplan. (2000). Thalidomide‐Induced Antigen‐Specific Immune Stimulation in Patients with Human Immunodeficiency Virus Type 1 and Tuberculosis. The Journal of Infectious Diseases. 181(3). 954–965. 43 indexed citations

16.

Spiegel, Hans, Graham S. Ogg, Megan E. Sheehy, et al.. (2000). Human Immunodeficiency Virus Type 1- and Cytomegalovirus-Specific Cytotoxic T Lymphocytes Can Persist at High Frequency for Prolonged Periods in the Absence of Circulating Peripheral CD4⁺T Cells. Journal of Virology. 74(2). 1018–1022. 75 indexed citations

17.

Corral, Laura G., Patrick Haslett, George W. Muller, et al.. (1999). Differential Cytokine Modulation and T Cell Activation by Two Distinct Classes of Thalidomide Analogues That Are Potent Inhibitors of TNF-α. The Journal of Immunology. 163(1). 380–386. 577 indexed citations breakdown →

18.

Haslett, Patrick, Victoria H. Freedman, & Gilla Kaplan. (1997). The emerging role of thalidomide therapy in HIV-infected patients. 14(5). 4 indexed citations

19.

Haslett, Patrick, et al.. (1997). The Metabolic and Immunologic Effects of Short-Term Thalidomide Treatment of Patients Infected with the Human Immunodeficiency Virus. AIDS Research and Human Retroviruses. 13(12). 1047–1054. 77 indexed citations

20.

Haslett, Patrick, et al.. (1997). Adverse Reactions to Thalidomide in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 24(6). 1223–1227. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact